ArticleOncotarget2015

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma.

Luigi Fattore et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.